From: Meeting individualized glycemic targets in primary care patients with type 2 diabetes in Spain
Category name | HbA1c target | Low/high risk | Patient characteristics | ||||
---|---|---|---|---|---|---|---|
Treatment | Previous hypoglycemia | Age | Duration of diabetes | Diabetes complicationsa | |||
ADA/EASD- 1 | <6.5 | Low | Any | Any | Any | <5 | No |
ADA/EASD-2 | <7 | Low | Any | Any | ≤75 | 5-9 | No |
ADA/EASD-3 | <8 | High | Any | Any | >75 | Any | Any |
Any | >10 | Any | |||||
Any | Any | Yes | |||||
SED-1 | ≤6.5 | Low | Any | Any | ≤70 | <10 | No |
SED-2 | ≤7.5 | High | Any | Any | >70 | Any | Any |
Any | >10 | Any | |||||
Any | Any | Yes | |||||
HYPO-1 | <7 | Low | Not insulin, not SU, not glinides | No | Any | Any | Any |
HYPO-2 | <7.5 | Low | Basal insulin, SU, or glinides | No | Any | Any | Any |
HYPO-3 | <8 | High | Insulin (≥2 doses) | Any | Any | Any | Any |
Any | Yes | Any | Any | Any |